Literature DB >> 23518484

A multidisciplinary clinical program is effective in stabilizing BMI and reducing transaminase levels in pediatric patients with NAFLD.

Stephanie DeVore1, Rohit Kohli, Kathleen Lake, Lynda Nicholas, Kim Dietrich, William F Balistreri, Stavra A Xanthakos.   

Abstract

BACKGROUND AND AIM: Weight loss is an effective treatment for children with nonalcoholic fatty liver disease (NAFLD), but it is extremely difficult to achieve outside of an intensive weight management program. We hypothesized that one can achieve success in improving NAFLD and weight-related outcomes in a structured and focused multidisciplinary clinical program feasible to implement in a gastroenterology clinic.
METHODS: We prospectively tracked the clinical status of our patients enrolled in a multidisciplinary program of dietary and exercise advice through an institutional review board-approved NAFLD registry. Each patient met with a gastroenterologist and dietitian every 3 months for 30 minutes to set individualized goals and monitor progress.
RESULTS: A total of 108 children have been enrolled in the registry, and of the 83 that were eligible for 1-year follow-up and included in the analysis, 39 patients returned, resulting in a 47% follow-up rate. These 39 patients showed statistically significant improvements in mean BMI z score (-0.1 U, P < 0.05), total (-11 mg/dL, P < 0.05) and low-density lipoprotein (9 mg/dL, P < 0.05) cholesterol, and serum alanine aminotransferase levels (-36 U/L) and aspartate aminotransferase levels (-22 U/L) levels.
CONCLUSIONS: A clinically feasible multidisciplinary program for obese pediatric patients with NAFLD stabilized BMI z score and significantly improved aminotransferase levels at 1-year follow-up.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23518484      PMCID: PMC3696482          DOI: 10.1097/MPG.0b013e318290d138

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  16 in total

Review 1.  Bariatric surgery for morbid obesity.

Authors:  Eric J DeMaria
Journal:  N Engl J Med       Date:  2007-05-24       Impact factor: 91.245

2.  NAFLD in children: a prospective clinical-pathological study and effect of lifestyle advice.

Authors:  Valerio Nobili; Matilde Marcellini; Rita Devito; Paolo Ciampalini; Fiorella Piemonte; Donatella Comparcola; Maria Rita Sartorelli; Paul Angulo
Journal:  Hepatology       Date:  2006-08       Impact factor: 17.425

3.  Effect of orlistat on weight and body composition in obese adolescents: a randomized controlled trial.

Authors:  Jean-Pierre Chanoine; Sarah Hampl; Craig Jensen; Mark Boldrin; Jonathan Hauptman
Journal:  JAMA       Date:  2005-06-15       Impact factor: 56.272

4.  Liver fat change in obese children after a 1-year nutrition-behavior intervention.

Authors:  Carlo Pozzato; Elvira Verduci; Silvia Scaglioni; Giovanni Radaelli; Michela Salvioni; Antonio Rovere; Gianpaolo Cornalba; Enrica Riva; Marcello Giovannini
Journal:  J Pediatr Gastroenterol Nutr       Date:  2010-09       Impact factor: 2.839

Review 5.  Hyperlipidemia in children with type 2 diabetes mellitus.

Authors:  Doris Taha
Journal:  J Pediatr Endocrinol Metab       Date:  2002-04       Impact factor: 1.634

6.  Design and validation of a histological scoring system for nonalcoholic fatty liver disease.

Authors:  David E Kleiner; Elizabeth M Brunt; Mark Van Natta; Cynthia Behling; Melissa J Contos; Oscar W Cummings; Linda D Ferrell; Yao-Chang Liu; Michael S Torbenson; Aynur Unalp-Arida; Matthew Yeh; Arthur J McCullough; Arun J Sanyal
Journal:  Hepatology       Date:  2005-06       Impact factor: 17.425

7.  Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial.

Authors:  Joel E Lavine; Jeffrey B Schwimmer; Mark L Van Natta; Jean P Molleston; Karen F Murray; Philip Rosenthal; Stephanie H Abrams; Ann O Scheimann; Arun J Sanyal; Naga Chalasani; James Tonascia; Aynur Ünalp; Jeanne M Clark; Elizabeth M Brunt; David E Kleiner; Jay H Hoofnagle; Patricia R Robuck
Journal:  JAMA       Date:  2011-04-27       Impact factor: 56.272

Review 8.  Effect of bariatric surgery on nonalcoholic fatty liver disease: systematic review and meta-analysis.

Authors:  Rajasekhara R Mummadi; Krishna S Kasturi; Swapna Chennareddygari; Gagan K Sood
Journal:  Clin Gastroenterol Hepatol       Date:  2008-08-19       Impact factor: 11.382

Review 9.  Bariatric surgery: a systematic review and meta-analysis.

Authors:  Henry Buchwald; Yoav Avidor; Eugene Braunwald; Michael D Jensen; Walter Pories; Kyle Fahrbach; Karen Schoelles
Journal:  JAMA       Date:  2004-10-13       Impact factor: 56.272

10.  Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis.

Authors:  Kittichai Promrat; David E Kleiner; Heather M Niemeier; Elizabeth Jackvony; Marie Kearns; Jack R Wands; Joseph L Fava; Rena R Wing
Journal:  Hepatology       Date:  2010-01       Impact factor: 17.425

View more
  25 in total

Review 1.  Fatty liver in childhood.

Authors:  Yesim Ozturk; Ozlem Bekem Soylu
Journal:  World J Hepatol       Date:  2014-01-27

Review 2.  Pediatric nonalcoholic fatty liver disease: Prevalence, diagnosis, risk factors, and management.

Authors:  Stavra A Xanthakos; Rohit Kohli
Journal:  Clin Liver Dis (Hoboken)       Date:  2012-09-25

Review 3.  Lifestyle Intervention as the Primary Treatment for Pediatric Nonalcoholic Fatty Liver Disease.

Authors:  Taisa Kohut; Jennifer Panganiban
Journal:  Clin Liver Dis (Hoboken)       Date:  2021-04-13

4.  NASPGHAN Clinical Practice Guideline for the Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease in Children: Recommendations from the Expert Committee on NAFLD (ECON) and the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN).

Authors:  Miriam B Vos; Stephanie H Abrams; Sarah E Barlow; Sonia Caprio; Stephen R Daniels; Rohit Kohli; Marialena Mouzaki; Pushpa Sathya; Jeffrey B Schwimmer; Shikha S Sundaram; Stavra A Xanthakos
Journal:  J Pediatr Gastroenterol Nutr       Date:  2017-02       Impact factor: 2.839

5.  Pediatric nonalcoholic fatty liver disease.

Authors:  T Mitsinikos; R Kohli
Journal:  Clin Liver Dis (Hoboken)       Date:  2018-04-20

Review 6.  Defining comprehensive models of care for NAFLD.

Authors:  Manuel Romero-Gómez; Jörn M Schattenberg; Jeffrey V Lazarus; Quentin M Anstee; Hannes Hagström; Kenneth Cusi; Helena Cortez-Pinto; Henry E Mark; Michael Roden; Emmanuel A Tsochatzis; Vincent Wai-Sun Wong; Zobair M Younossi; Shira Zelber-Sagi
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-06-25       Impact factor: 46.802

Review 7.  Nonmedicinal interventions in nonalcoholic fatty liver disease.

Authors:  Manuela G Neuman; Radu M Nanau; Lawrence B Cohen
Journal:  Can J Gastroenterol Hepatol       Date:  2015 Jun-Jul

8.  Incidence of Nonalcoholic Fatty Liver Disease in Children: 2009-2018.

Authors:  Amandeep K Sahota; Warren L Shapiro; Kimberly P Newton; Steven T Kim; Joanie Chung; Jeffrey B Schwimmer
Journal:  Pediatrics       Date:  2020-12       Impact factor: 7.124

Review 9.  Nutrition, nonalcoholic fatty liver disease and the microbiome: recent progress in the field.

Authors:  Miriam B Vos
Journal:  Curr Opin Lipidol       Date:  2014-02       Impact factor: 4.776

10.  High prevalence of hepatitis B non-immunity in paediatric non-alcoholic fatty liver disease patients.

Authors:  Minesh Mehta; Crystal Slaughter; Stavra A Xanthakos; Rohit Kohli
Journal:  Dig Liver Dis       Date:  2014-04-16       Impact factor: 4.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.